The role of VEGF in triple-negative breast cancer: where do we go from here?
Publication
, Journal Article
Dent, SF
Published in: Ann Oncol
October 2009
Duke Scholars
Published In
Ann Oncol
DOI
EISSN
1569-8041
Publication Date
October 2009
Volume
20
Issue
10
Start / End Page
1615 / 1617
Location
England
Related Subject Headings
- Vascular Endothelial Growth Factor A
- Oncology & Carcinogenesis
- Humans
- Genes, BRCA1
- Female
- Breast Neoplasms
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Dent, S. F. (2009). The role of VEGF in triple-negative breast cancer: where do we go from here? Ann Oncol, 20(10), 1615–1617. https://doi.org/10.1093/annonc/mdp410
Dent, S. F. “The role of VEGF in triple-negative breast cancer: where do we go from here?” Ann Oncol 20, no. 10 (October 2009): 1615–17. https://doi.org/10.1093/annonc/mdp410.
Dent SF. The role of VEGF in triple-negative breast cancer: where do we go from here? Ann Oncol. 2009 Oct;20(10):1615–7.
Dent, S. F. “The role of VEGF in triple-negative breast cancer: where do we go from here?” Ann Oncol, vol. 20, no. 10, Oct. 2009, pp. 1615–17. Pubmed, doi:10.1093/annonc/mdp410.
Dent SF. The role of VEGF in triple-negative breast cancer: where do we go from here? Ann Oncol. 2009 Oct;20(10):1615–1617.
Published In
Ann Oncol
DOI
EISSN
1569-8041
Publication Date
October 2009
Volume
20
Issue
10
Start / End Page
1615 / 1617
Location
England
Related Subject Headings
- Vascular Endothelial Growth Factor A
- Oncology & Carcinogenesis
- Humans
- Genes, BRCA1
- Female
- Breast Neoplasms
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis